Astrazeneca Pharma India jumps 8% after job cuts in biopharma unit
** Shares of Astrazeneca Pharma India Ltd ASTR.NS jump
8.3% to 6,888.90 rupees, set for its best day in 3 months
** Drugmaker confirms job losses in its biopharma unit but
does not disclose number of employees affected
** The Economic Times daily reported earlier in the day that
about 125 employees, or half of the biopharma unit's workforce,
is being laid off
** About 194,000 shares traded, 14.6x 30-day avg volume
** Stock extends YTD gains to ~25%, set for third-straight
year of growth
(Reporting by Nandan Mandayam in Bengaluru)
((Nandan.Mandayam@thomsonreuters.com; Mobile: +91 9591011727;))
Recent news on Astrazeneca Pharma India
See all newsBrief: Astrazeneca Pharma India Receives Permission To Import And Sell Trastuzumab Deruxtecan For Additional Indication
Brief: Astrazeneca Pharma Says Bhavana Agrawal Resigns As CFO
Brief: Astrazeneca Pharma India Receives Permission To Import And Sell Benralizumab For Additional Indication
Brief: Astrazeneca Pharma India Receives Permission To Import Benralizumab (Fasenra) For Additional Indication
Brief: Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan